Ocugen, Inc. (OCGN)

Ocugen Statistics

Total Valuation

Ocugen has a market cap or net worth of $214.38 million. The enterprise value is $193.66 million.

Market Cap	214.38M
Enterprise Value	193.66M

Important Dates

The last earnings date was Friday, November 8, 2024, before market open.

Earnings Date	Nov 8, 2024
Ex-Dividend Date	n/a

Share Statistics

Ocugen has 291.32 million shares outstanding. The number of shares has increased by 11.56% in one year.

Current Share Class	291.32M
Shares Outstanding	291.32M
Shares Change (YoY)	+11.56%
Shares Change (QoQ)	+8.03%
Owned by Insiders (%)	1.37%
Owned by Institutions (%)	27.45%
Float	287.33M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	43.23
Forward PS	n/a
PB Ratio	5.53
P/TBV Ratio	5.55
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	41.20
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.58, with a Debt / Equity ratio of 0.17.

Current Ratio	2.58
Quick Ratio	2.46
Debt / Equity	0.17
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -103.30% and return on invested capital (ROIC) is -58.38%.

Return on Equity (ROE)	-103.30%
Return on Assets (ROA)	-47.98%
Return on Capital (ROIC)	-58.38%
Revenue Per Employee	$72,308
Profits Per Employee	-$786,831
Employee Count	65
Asset Turnover	0.07
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +65.78% in the last 52 weeks. The beta is 3.82, so Ocugen's price volatility has been higher than the market average.

Beta (5Y)	3.82
52-Week Price Change	+65.78%
50-Day Moving Average	0.92
200-Day Moving Average	1.30
Relative Strength Index (RSI)	31.27
Average Volume (20 Days)	5,199,061

Short Selling Information

The latest short interest is 57.00 million, so 19.56% of the outstanding shares have been sold short.

Short Interest	57.00M
Short Previous Month	54.40M
Short % of Shares Out	19.56%
Short % of Float	19.84%
Short Ratio (days to cover)	14.01

Income Statement

In the last 12 months, Ocugen had revenue of $4.70 million and -$51.14 million in losses. Loss per share was -$0.20.

Revenue	4.70M
Gross Profit	-26.92M
Operating Income	-52.44M
Pretax Income	-50.86M
Net Income	-51.14M
EBITDA	-50.89M
EBIT	-52.44M
Loss Per Share	-$0.20

Balance Sheet

The company has $38.70 million in cash and $6.78 million in debt, giving a net cash position of $31.91 million or $0.11 per share.

Cash & Cash Equivalents	38.70M
Total Debt	6.78M
Net Cash	31.91M
Net Cash Per Share	$0.11
Equity (Book Value)	40.63M
Book Value Per Share	0.14
Working Capital	24.91M

Cash Flow

In the last 12 months, operating cash flow was -$43.08 million and capital expenditures -$6.09 million, giving a free cash flow of -$49.17 million.

Operating Cash Flow	-43.08M
Capital Expenditures	-6.09M
Free Cash Flow	-49.17M
FCF Per Share	-$0.17

Margins

Gross Margin	n/a
Operating Margin	-1,115.79%
Pretax Margin	-1,088.17%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Ocugen does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.56%
Shareholder Yield	-11.56%
Earnings Yield	-22.67%
FCF Yield	-21.80%

Analyst Forecast

The average price target for Ocugen is $5.67, which is 670.49% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$5.67
Price Target Difference	670.49%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	108.93%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Ocugen has an Altman Z-Score of -1.87 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.87
Piotroski F-Score	2